UK CTAP Briefing on Vitamin D - National Core Studies

The UK COVID-19 Therapeutics Advisory Panel was convened to review and select potential COVID-19 therapeutics for publicly funded clinical trials. Briefs were prepared by the UKRI Secretariat Due Diligence Team to support the work of the Panel. The aim of briefs was to summarise and qualify the evidence for candidate drugs proposed by industry, academia and the general public through an open portal. Briefs were prepared rapidly to meet tight deadlines in response to the COVID-19 pandemic. They reflect the state of knowledge regarding COVID-19 and drug candidate at the date of completion (Chinnery et al., 2021). This brief is published for transparency and historical record and should not be understood as a peer reviewed scientific publication. The date of completion is marked, and the brief is redacted where commercial sensitivities are involved.